David M. Smadja

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Viral Diagnostics, Immunodeficiencies, Viral Immunity +19

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

David M. Smadja, Coralie L. Guérin, Richard Chocron et al. · Angiogenesis · 2020 · 258 citations · Full text

Circulating Endothelial Cells

David M. Smadja, Pascale Gaussem, Laëtitia Mauge et al. · Circulation · 2009 · 153 citations · Full text

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

David M. Smadja, Qun‐Ying Yue, Richard Chocron et al. · European Respiratory Journal · 2021 · 139 citations · Full text

Virus Epidemiology, Mrna Vaccines, Immunology +21

PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System

David M. Smadja, Ivan Bièche, Georges Uzan et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 127 citations · Full text